Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
PR Newswire•21/09/2026•10:57 ET
0
Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) PR Newswire
FLORENCE, Italy, NAARDEN, Netherlands and MIAMI, Sept. 21, 2026
Get started
Create a free account to read the full story and Whiz Insights.